PGM3 regulates beta-catenin activity to promote colorectal cancer cell progression
2022 · Experimental Biology and Medicine · 11 citations
https://doi.org/10.1177/15353702221101810
N
Nan Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
37
Citations
4
h-index
1
i10-index
Nan Zhang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Ferroptosis and cancer prognosis & Immune cells in cancer. The author has an h-index of 4, co-authored 13 publications.
ORCID: 0009-0005-1392-8689Papers by this author
worksTranscriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells
2023 · Translational Oncology · 4 citations
https://doi.org/10.1016/j.tranon.2023.101842
Prediction of Prognostic Features Based on Neutrophil-Related Genes for Lung Squamous Cell Carcinoma Reveals Immune Landscape and Drug Candidates
2024 · Revista de investigaci�n Cl�nica · 0 citations
https://doi.org/10.24875/ric.23000262
Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-025-13794-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat